Is Progressive Supranuclear Palsy a Type of Alzheimer's?

No, Progressive Supranuclear Palsy (PSP) is not a type of Alzheimer’s disease. While both conditions share a biological feature—the buildup of a protein called tau in the brain—they are entirely distinct diseases ^[1][2]. Because doctors often mention “tau tangles” when discussing both conditions, it is common for patients and families to confuse the two. However, the specific type of tau protein, the areas of the brain affected, and the symptoms experienced are very different ^[3].

The Role of Tau in Both Diseases

Tau is a normal protein that helps stabilize the internal structure of brain cells. In certain diseases, known as tauopathies, this protein becomes defective, clumps together, and damages brain cells ^[4].

• In Alzheimer’s disease, the brain accumulates both defective tau and another protein called amyloid-beta. The tau tangles in Alzheimer’s contain a mix of different shapes of the tau protein ^[5].
• In Progressive Supranuclear Palsy, amyloid-beta is not a primary factor ^[6]. Instead, PSP is considered a “primary 4-repeat (4R) tauopathy” ^[3]. This means the buildup consists almost exclusively of one specific shape of tau (the 4R version), which forms unique clumps and deposits that are different from those seen in Alzheimer’s ^[7]. Knowing this specific biology helps researchers develop targeted treatments and fluid-based tests for PSP ^[8].

How the Brain is Affected

Because the tau buildup in each disease targets different areas of the brain, the symptoms are vastly different.

• Alzheimer’s disease typically begins in the hippocampus and entorhinal cortex—areas of the brain responsible for memory, learning, and thinking ^[9]. This is why memory loss is usually the first and most prominent symptom.
• PSP primarily attacks the midbrain, basal ganglia, and the frontal lobes of the brain ^[10][11]. The midbrain and basal ganglia control physical movement, balance, and coordination. This leads to the classic physical symptoms of PSP: frequent falls (often backward), stiffness, and difficulty controlling eye movements ^[12][13]. You may even see a reference to the hummingbird sign on your brain MRI, which is a specific pattern of midbrain shrinking that helps doctors diagnose PSP ^[14].
• Cognitive Differences: While Alzheimer’s causes memory loss, the frontal lobe damage in PSP leads to different cognitive and behavioral changes. People with PSP may experience executive dysfunction (trouble with planning and organizing), apathy, or impulsivity, but they typically do not forget their personal history or recent events in the way Alzheimer’s patients do ^[12][15].

Why the Distinction Matters

Understanding that you have PSP and not Alzheimer’s is crucial for managing your care. Medications designed to treat memory loss in Alzheimer’s are not effective for PSP and can sometimes cause adverse side effects ^[16]. Furthermore, because PSP can look like Parkinson’s disease early on, it is important to know that it often does not respond well to standard Parkinson’s medications ^[11].

While this can sound daunting, an accurate diagnosis empowers you to focus on what does work. The current best standard of care for PSP is proactive symptom management through a multidisciplinary care team. This team typically includes a neurologist, a physical therapist to help prevent falls, an occupational therapist for daily living adaptations, a speech-language pathologist for swallowing and voice clarity, and sometimes a neuro-ophthalmologist for eye symptoms. Focusing on therapy and practical support can significantly improve safety and quality of life.